Skip to main content
Clinical Trials/NCT03945123
NCT03945123CompletedNot Applicable

Effect of Korea Red Ginseng on Non-alcoholic Fatty Liver Disease

Chuncheon Sacred Heart Hospital1 site in 1 country94 target enrollmentStarted: January 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
94
Locations
1
Primary Endpoint
Liver enzyme

Study Overview

Brief Summary

Korea Red Ginseng (KRG) has effect on liver function

Detailed Description

Korea Red Ginseng (KRG) has been known as a natural product with anti-inflammatory effect in liver disease. Gut microbiota plays an important roles in the pathophysiology of nonalcoholic statohepatitis (NASH). We evaluated the effect of KRG on the pathophysiology of NASH

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
37 Years to 63 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •AST or ALT level > 50 IU/L

Exclusion Criteria

  • •Viral hepatitis
  • •Alcoholic hepatitis
  • •Autoimmune hepatitis
  • •Pancreatitis
  • •Hemochromatosis
  • •Wilson's disease
  • •Drug induced liver injury

Arms & Interventions

Ginseng trial

Experimental

compare experimental group to controlled group

Intervention: Red ginseng (Dietary Supplement)

Outcomes

Primary Outcomes

Liver enzyme

Time Frame: 1year

Decrease liver enzyme level

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Chuncheon Sacred Heart Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ki Tae Suk

Proffesor

Chuncheon Sacred Heart Hospital

Study Sites (1)

Loading locations...

Similar Trials